Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09654.x/fullpdf
Reference24 articles.
1. A combined analysis of European Organisation for Cancer Research and Treatment of Cancer and Medical Research Cancer clinical trials for the prophylactic treatment of stage Ta-T1 bladder cancer;Pawinski;J Urol,1996
2. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008
3. Risk-adapted use of intravesical chemotherapy;Lerner;BJU Int,2008
4. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder;Lamm;J Urol,1995
5. Intravesical therapy of superficial bladder cancer;Malmstrom;Crit Rev Oncol Hematol,2003
Cited by 169 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitomycin C vs. Bacillus Calmette–Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients—A comparative analysis from a single center;Urologic Oncology: Seminars and Original Investigations;2024-07
2. TVNIM, bientôt des alternatives au BCG;Progrès en Urologie - FMC;2024-07
3. Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC);Research and Reports in Urology;2024-04
4. Heat treatment in health and disease: How water-filtered infrared-A (wIRA) irradiation affects key cellular mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to healthy donors;Journal of Thermal Biology;2024-02
5. Efficacy and safety of HIVEC versus ETFT in non-muscle-invasive bladder cancer: A systematic review and meta-analysis;Asian Journal of Surgery;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3